| |
| |
|
| Insider
Information: |
Paul Steven M |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
1,185,025 |
|
|
Indirect Shares
|
632,151 |
|
|
| Direct
Value |
$37,673,864 |
|
|
|
Indirect Value
|
$30,104,525 |
|
|
| Total
Shares |
1,817,176 |
|
|
| Total
Value |
$67,778,389 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
EVP, Science and Techn... |
2010-02-01 |
38,897 |
2010-02-01 |
39,040 |
Premium* |
|
|
Sigma-Aldrich Corp |
SIAL |
Director |
2015-11-18 |
0 |
2007-01-02 |
0 |
Premium* |
|
|
Sage Therapeutics, Inc. |
SAGE |
|
2019-03-21 |
272,777 |
2022-11-28 |
593,111 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2022-04-01 |
1,000 |
2015-01-26 |
0 |
Premium* |
|
|
Voyager Therapeutics, Inc. |
VYGR |
President and CEO, Dir... |
2016-01-14 |
872,351 |
|
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2024-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
131 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SIAL |
Sigma-Aldrich Corp |
|
– • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,200 |
2,400 |
0 |
- |
|
| SIAL |
Sigma-Aldrich Corp |
Director |
– • – |
2014-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
373 |
7,573 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Director |
– • – |
2014-07-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
793,650 |
|
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Director |
– • – |
2014-07-23 |
4 |
B |
$18.00 |
$180,000 |
D/D |
10,000 |
803,650 |
2.39 |
- |
|
| SIAL |
Sigma-Aldrich Corp |
Director |
– • – |
2015-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
684 |
8,257 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2015-01-26 |
4 |
B |
$95.00 |
$95,000 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2015-04-01 |
4 |
S |
$48.51 |
$970,200 |
D/D |
(20,000) |
783,650 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Director |
– • – |
2015-05-01 |
4 |
AS |
$53.31 |
$1,066,200 |
D/D |
(20,000) |
763,650 |
0 |
- |
|
| SIAL |
Sigma-Aldrich Corp |
Director |
– • – |
2015-05-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,779 |
478 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2015-06-01 |
4 |
AS |
$71.36 |
$1,446,799 |
D/D |
(20,000) |
743,650 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2015-07-01 |
4 |
AS |
$67.46 |
$1,388,028 |
D/D |
(20,000) |
723,650 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2015-08-03 |
4 |
AS |
$66.42 |
$1,341,692 |
D/D |
(20,000) |
703,650 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2015-09-01 |
4 |
AS |
$52.10 |
$1,048,184 |
D/D |
(20,000) |
683,650 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
President and CEOOfficer |
• • – |
2015-11-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
862,351 |
|
- |
|
| SIAL |
Sigma-Aldrich Corp |
Director |
– • – |
2015-11-18 |
4 |
D |
$140.00 |
$66,920 |
D/D |
(478) |
0 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
President and CEO |
• • – |
2016-01-14 |
4 |
B |
$14.07 |
$140,690 |
D/D |
10,000 |
872,351 |
2.81 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2016-02-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,081 |
678,569 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2017-01-31 |
4 |
A |
$3.15 |
$6,848 |
D/D |
2,174 |
690,851 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2018-03-06 |
4 |
AS |
$172.00 |
$9,999,908 |
D/D |
(58,139) |
632,712 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2019-02-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
241,695 |
272,777 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2019-02-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
241,695 |
241,695 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2019-02-15 |
4 |
AS |
$161.02 |
$7,964,210 |
I/I |
(49,461) |
74,443 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2019-02-19 |
4 |
AS |
$161.37 |
$249,373 |
I/I |
(1,543) |
72,900 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2019-02-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
122,400 |
193,300 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2019-02-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
122,400 |
119,295 |
0 |
- |
|
131 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
